F. TAS Et Al. , "Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.," American journal of clinical oncology , vol.24, no.2, pp.148-9, 2001
TAS, F. Et Al. 2001. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.. American journal of clinical oncology , vol.24, no.2 , 148-9.
TAS, F., AYKAN, F., AYDINER, A., Yasasever, V., & TOPUZ, E., (2001). Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.. American journal of clinical oncology , vol.24, no.2, 148-9.
TAS, Faruk Et Al. "Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.," American journal of clinical oncology , vol.24, no.2, 148-9, 2001
TAS, Faruk Et Al. "Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.." American journal of clinical oncology , vol.24, no.2, pp.148-9, 2001
TAS, F. Et Al. (2001) . "Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.." American journal of clinical oncology , vol.24, no.2, pp.148-9.
@article{article, author={Faruk TAŞ Et Al. }, title={Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.}, journal={American journal of clinical oncology}, year=2001, pages={148-9} }